GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, manufacturing, and marketing of pharmaceuticals, vaccines, and health-related consumer products across the United Kingdom, the United States and globally.

• Pharmaceuticals:
  Offers medicines in key therapeutic areas including respiratory, HIV, immuno-inflammation, oncology, antiviral, central nervous system, cardiovascular, urogenital, metabolic, antibacterial, and dermatology.

• Vaccines:
  Develops and distributes vaccines targeting various infectious diseases.

• Consumer Healthcare:
  Provides over-the-counter products in wellness, oral health, nutrition, and skin health categories. Formats include nasal sprays, tablets, syrups, lozenges, transdermal patches, infant drops, wipes, gels, effervescents, toothpaste, toothbrushes, mouthwashes, denture care, creams, lip balms, and gummies.

• Pharmaceuticals R&D:
  Focuses on drug discovery and early-stage development across its core therapeutic areas.

• Partnerships & Collaborations:
  Maintains R&D and strategic agreements with organizations including 23andMe, Lyell Immunopharma, Novartis, Sanofi, Surface Oncology, Progentec Diagnostics, Alector, CureVac, IDEAYA Biosciences, and Vir Biotechnology.

The company was formerly known as GlaxoSmithKline plc until May 2022.

GSK plc was founded in 1715 and is headquartered in Brentford, United Kingdom.